Abstract
Breast cancer is the most common malignancy in women. Screening mammography can detect cancer in its early stages, when it is potentially curable. Adjuvant chemotherapy is of major benefit in node-positive patients. It is also beneficial in certain node-negative patients with a high risk of breast cancer recurrence; these patients should be identified and offered adjuvant therapy or enrolled in a clinical trial.
MeSH terms
-
Adjuvants, Pharmaceutic / administration & dosage
-
Adjuvants, Pharmaceutic / pharmacology
-
Adjuvants, Pharmaceutic / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / epidemiology
-
Breast Neoplasms / pathology
-
Clinical Protocols / standards
-
Clinical Trials as Topic
-
Decision Trees
-
Female
-
Humans
-
Neoplasm Staging
-
Prognosis
-
Risk Factors
-
Tamoxifen / administration & dosage
-
Tamoxifen / pharmacology
-
Tamoxifen / therapeutic use*
Substances
-
Adjuvants, Pharmaceutic
-
Tamoxifen